USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
2021 Highlights and What to Expect in 2022
02-Dec-2021
North America
Market Research
MG4D-01-00-00-00
HC03481-NA-MT_26028
The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond.
It addresses the impact of innovative modalities, technologies, and recent drug approvals, such as gene and cell therapy, monoclonal antibodies,
RNA-based therapeutics, and the increasing use of health data through real-world evidence and artificial intelligence. The need to gain access to early-stage drugs and novel technologies has led to a higher rate of licensing and mergers with small biopharma that are developing the same. In addition, patient engagement has been driving digital partnerships centered around digital therapeutics, decentralized clinical trials, remote monitoring, and telemedicine.
The study also provides critical insights into the key regulatory, reimbursement, and policy updates for 2021, ranging from health data standardization and quality regulation to direct drug pricing negotiations and biosimilars & generics encouragement.
Key Issue Addressed
- What should we expect in the global pharmaceutical industry in 2022?
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Strategic Imperative 8™ on the Pharmaceuticals Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Pharmaceuticals—Factors Affecting Growth
Growth Opportunity Analysis for the Global Pharmaceutical Industry
2021 Highlights and What to Expect in 2022
2021 Highlights and What to Expect in 2022 (continued)
2021 Highlights and What to Expect in 2022 (continued)
Growth Drivers
Growth Restraints
Market Snapshot—Next-generation Biologics Modalities
Key FDA Approvals for Novel Drugs
Key FDA Approvals for Novel Drugs (continued)
Key FDA Approvals for Novel Drugs (continued)
Key FDA Approvals for Novel Drugs (continued)
Key FDA Approvals for Novel Drugs—Takeaways
Key M&A Deals
Key M&A Deals in the Pharma Industry—Takeaways
Key Product Licensing Deals
Key Product Licensing Deals (continued)
Key Product Licensing Deals (continued)
Key Product Licensing Deals—Takeaways
Key Digital Partnership Deals
Key Digital Partnership Deals (continued)
Key Digital Partnership Deals—Key Takeaways
Key Digital Partnership Deals—Key Takeaways (continued)
Key Regulatory, Reimbursement, and Policy Updates
Key Regulatory, Reimbursement, and Policy Updates (continued)
Key Regulatory, Reimbursement, and Policy Updates (continued)
Key Regulatory, Reimbursement, and Policy Updates (continued)
Key Regulatory, Reimbursement, and Policy Updates (continued)
Key Regulatory, Reimbursement, and Policy Updates (continued)
Key Regulatory, Reimbursement, and Policy Updates—Takeaways
Growth Opportunity 1: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity
Growth Opportunity 1: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity (continued)
Growth Opportunity 2: Integrated and RWE-supported Drug Development Platforms/Solutions to Improve User Experience
Growth Opportunity 2: Integrated and RWE-supported Drug Development Platforms/Solutions to Improve User Experience (continued)
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Key Issue Addressed
- What should we expect in the global pharmaceutical industry in 2022
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Delfina Huergo |
| Industries | Healthcare |
| WIP Number | MG4D-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,9568-B1,9611-B1 |
Global Pharmaceutical Industry Growth Opportunities
$2,450.00
Special Price $1,837.50 save 25 %